Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Study aimed to assess the reproducibility of PET imaging using AH111585 (18F) Injection.
Subjects are evaluable if they undergo 2 administrations of AH111585 (18F) Injection (3 to 8
days apart) and the corresponding PET acquisitions, and tumors demonstrate detectable levels
of 18F uptake on PET.
Phase:
Phase 2
Details
Lead Sponsor:
GE Healthcare
Collaborators:
BIAFFIN GmbH & Co. KG (Biomolecular Interaction Analyses) i3 Statprobe Quintiles, Inc.